Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Danaher Corp. (GB:0R2B)
LSE:0R2B
Holding GB:0R2B?
Track your performance easily
0R2B Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$182.16 - $283.88
Previous Close$266
Volume38.53K
Average Volume (3M)6.78K
Market Cap
$192.85B
Enterprise Value$209.86B
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$17.01B
Price to Earnings (P/E)47.5
Beta0.88
Next Earnings
Oct 17, 2024EPS Estimate
$1.56Last Dividend Ex-Date
Jun 28, 2024Dividend Yield0.39%
Share Statistics
EPS (TTM)5.63
Shares Outstanding722,213,081
10 Day Avg. Volume15,039
30 Day Avg. Volume6,784
Standard Deviation0.07
R-Squared0.03
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)-18.45
Price to Sales (P/S)9.14
Price to Cash Flow (P/CF)34.00
P/FCF Ratio42.70
Enterprise Value/Market CapN/A
Enterprise Value/Revenue9.94
Enterprise Value/Gross Profit14.95
Enterprise Value/Ebitda31.16
Forecast
1Y Price Target
$280.93Price Target Upside5.61% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering14
Danaher News
Bulls Say, Bears Say
Bulls Say
Buyback ProgramDHR's atypical buyback of $4.5 billion for 19 million shares further supports the view that a solid bioprocess recovery is at hand.
Market DynamicsThe combination of normalized ordering patterns, sequential order growth, and a strong book-to-bill all point towards a progressive recovery in the market.
Stock PerformanceDHR's stock rallied after the bioprocess led 2Q beat and management confidence that the bioprocess destock is effectively over and market demand is healthy.
Bears Say
Geographic WeaknessNo major improvement has been seen in China, and none is expected until 2025.
Market PerformanceLife Sciences markets remain weak, with Instruments and select areas of consumables being challenged.
ValuationThe main concern is valuation, with shares trading at a 30% premium to Tools, near the Covid-era peak spread, making the risk/reward seem balanced.
---
Options Prices
Currently, No data available
---
Ownership Overview
9.41% Insiders
29.67% Mutual Funds
39.18% Other Institutional Investors
21.74% Public Companies and
Individual Investors
0R2B FAQ
What was Danaher Corp.’s price range in the past 12 months?
Danaher Corp. lowest share price was $182.16 and its highest was $283.88 in the past 12 months.
What is Danaher Corp.’s market cap?
Currently, no data Available
When is Danaher Corp.’s upcoming earnings report date?
Danaher Corp.’s upcoming earnings report date is Oct 17, 2024 which is in 46 days.
How were Danaher Corp.’s earnings last quarter?
Danaher Corp. released its earnings results on Jul 23, 2024. The company reported $1.72 earnings per share for the quarter, beating the consensus estimate of $1.573 by $0.147.
Is Danaher Corp. overvalued?
According to Wall Street analysts Danaher Corp.’s price is currently Undervalued.
Does Danaher Corp. pay dividends?
Danaher Corp. pays a Quarterly dividend of $0.27 which represents an annual dividend yield of 0.39%. See more information on Danaher Corp. dividends here
What is Danaher Corp.’s EPS estimate?
Danaher Corp.’s EPS estimate is $1.56.
How many shares outstanding does Danaher Corp. have?
Danaher Corp. has 722,213,100 shares outstanding.
What happened to Danaher Corp.’s price movement after its last earnings report?
Danaher Corp. reported an EPS of $1.72 in its last earnings report, beating expectations of $1.573. Following the earnings report the stock price went up 6.997%.
Which hedge fund is a major shareholder of Danaher Corp.?
Among the largest hedge funds holding Danaher Corp.’s share is Fisher Asset Management LLC. It holds Danaher Corp.’s shares valued at 1B.
---
Danaher Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$280.93 (5.61% Upside)
$280.93 (5.61% Upside)
Blogger Sentiment
Bullish
GB:0R2B Sentiment 93%
Sector Average 68%
Sector Average 68%
Insider Transactions
Sold Shares
Worth $12.4M over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
15.52%
12-Months-Change
Fundamentals
Return on Equity
8.36%
Trailing 12-Months
Asset Growth
-7.48%
Trailing 12-Months
Company Description
Danaher Corp.
Founded in 1969 and headquartered in Washington, DC, Danaher Corp. engages in manufacturing, designing and marketing of professional, medical, industrial and commercial products and services. The company operates through three segments, including Life Sciences, Diagnostics, and Environmental & Applied Solutions.
---
0R2B Company Deck
---
0R2B Earnings Call
Q2 2024
0:00 / 0:00
---
0R2B Revenue Breakdown
40.09% Diagnostics
30.02% Biotechnology
29.89% Life Sciences
---
0R2B Stock 12 Month Forecast
Average Price Target
$280.93
▲(5.61% Upside)
Technical Analysis
Best Analysts Covering 0R2B
1 Year
1 Year Success Rate
9/11 ratings generated profit
1 Year Average Return
+11.33%
assigned a buy rating last month
Copying Conor McNamara's trades and holding each position for 1 Year would result in 81.82% of your transactions generating a profit, with an average return of +11.33% per trade.
---